HealthEquity, Inc. (HQY)
NASDAQ: HQY · Real-Time Price · USD
88.42
+1.17 (1.34%)
Sep 30, 2026, 2:51 PM EDT - Market open
HealthEquity Ratios and Metrics
Market cap in millions USD. Fiscal year is February - January.
Millions USD. Fiscal year is Feb - Jan.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 |
| 7,314 | 7,319 | 9,569 | 6,485 | 5,150 | 4,468 | |
Market Cap Growth | -12.06% | -23.51% | 47.56% | 25.91% | 15.28% | -30.55% |
Enterprise Value | 8,029 | 8,038 | 10,382 | 7,085 | 5,938 | 4,829 |
Last Close Price | 87.25 | 85.67 | 110.42 | 75.58 | 60.85 | 53.44 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 |
PE Ratio | 31.98 | 34.01 | 98.96 | 116.40 | - | - |
Forward PE | 17.46 | 19.75 | 31.70 | 28.55 | 36.76 | 40.27 |
PS Ratio | 5.39 | 5.57 | 7.98 | 6.49 | 5.98 | 5.91 |
PB Ratio | 3.63 | 3.47 | 4.53 | 3.19 | 2.72 | 2.41 |
P/FCF Ratio | 15.04 | 16.08 | 28.33 | 26.89 | 34.97 | 33.82 |
P/OCF Ratio | 14.97 | 16.01 | 28.16 | 26.71 | 34.19 | 31.69 |
PEG Ratio | 1.07 | 1.16 | 1.28 | 1.17 | 1.33 | 3.58 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 |
EV/Sales Ratio | 5.91 | 6.12 | 8.65 | 7.09 | 6.89 | 6.38 |
EV/EBITDA Ratio | 15.68 | 16.67 | 28.42 | 25.20 | 29.86 | 27.17 |
EV/EBIT Ratio | 22.62 | 24.55 | 51.18 | 55.30 | 157.71 | 119.04 |
EV/FCF Ratio | 16.51 | 17.66 | 30.74 | 29.38 | 40.32 | 36.56 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 |
Debt / Equity Ratio | 0.49 | 0.48 | 0.52 | 0.46 | 0.53 | 0.54 |
Debt / EBITDA Ratio | 1.88 | 2.06 | 2.99 | 3.24 | 4.78 | 5.29 |
Debt / FCF Ratio | 1.99 | 2.20 | 3.28 | 3.87 | 6.75 | 7.63 |
Net Debt / Equity Ratio | 0.36 | 0.32 | 0.38 | 0.26 | 0.39 | 0.42 |
Net Debt / EBITDA Ratio | 1.39 | 1.42 | 2.22 | 1.88 | 3.72 | 4.40 |
Net Debt / FCF Ratio | 1.47 | 1.50 | 2.41 | 2.19 | 5.03 | 5.93 |
Asset Turnover | 0.41 | 0.39 | 0.36 | 0.32 | 0.28 | 0.26 |
Quick Ratio | 2.46 | 2.82 | 2.65 | 4.35 | 2.68 | 2.04 |
Current Ratio | 2.99 | 3.27 | 3.06 | 4.76 | 2.92 | 2.29 |
Return on Equity (ROE) | 11.43% | 10.19% | 4.66% | 2.83% | -1.40% | -2.74% |
Return on Assets (ROA) | 6.65% | 5.99% | 3.84% | 2.56% | 0.76% | 0.87% |
Return on Invested Capital (ROIC) | 9.97% | 8.89% | 6.16% | 3.66% | 1.43% | 1.70% |
Return on Capital Employed (ROCE) | 11.40% | 10.20% | 6.20% | 4.20% | 1.30% | 1.40% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 |
Earnings Yield | 3.22% | 2.94% | 1.01% | 0.86% | -0.51% | -0.99% |
FCF Yield | 6.65% | 6.22% | 3.53% | 3.72% | 2.86% | 2.96% |
Buyback Yield / Dilution | 3.29% | 1.52% | -2.15% | -2.98% | -1.57% | -9.85% |